Clinical Outcome and Complication of Endoscopic Endonasal Transsphenoidal Surgery (ETSS) for Pituitary Adenoma: A Retrospective Study at Prime Teaching Hospital Peshawar by Khan, Musawer et al.
 





PAKISTAN JOURNAL OF NEUROLOGICAL SURGERY QUARTERLY – 




Clinical Outcome and Complication of Endoscopic Endonasal 
Transsphenoidal Surgery (ETSS) for Pituitary Adenoma: A 
Retrospective Study at Prime Teaching Hospital Peshawar 
 
Musawer Khan1, Arif Hussain2, Mumtaz Ali2 
1Mardan Medical Complex, Teaching Hospital, Mardan, Pakistan 
2Department of Neurosurgery, Prime Teaching Hospital, Peshawar – Pakistan 
 
ABSTRACT 
Objectives:  The study aimed to ascertain the clinical outcome and complications of endoscopic endonasal 
transsphenoidal surgery (ETSS) for pituitary adenomas. 
Material & Methods:  A retrospective study conducted at the Department of Neurosurgery Prime Teaching 
Hospital Peshawar, Pakistan. Pituitary adenoma was diagnosed in 89 patients on MRI Brain with contrast and 
post-surgical biopsy. Post-surgical outcomes and complications were documented. 
Results:  Out of 89 patients, 54% were male, and 46% female patients. The mean age was 42 ± 5 years. 
Headache was reported in 92% as a most common presentation, followed by decreased visual acuity in 62 %, 
amenorrhea in 22%, and acromegaly in 29% of patients. Overall, the symptoms related to surgical 
improvement were observed in 72% of patients. A good surgical outcome was observed in 80% of patients 
with microadenomas, as compared to the patients with macroadenomas. The most common complication was 
the transient diabetes insipidus followed by Cerebrospinal fluid (CSF) leak and post-operative hematoma. 
Conclusion:  Endoscopic endonasal transsphenoidal surgery (ETSS) is a safe, less invasive, cosmetically 
effective technological advancement for pituitary adenomas. 
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INTRODUCTION 
Globally, the overall incidence of pituitary 
adenomas is around 17%.1 Transsphenoidal 
surgery (TSS) is a very safe and effective surgical 
approach for most pituitary micro and macro 
adenomas, and is offered as a first choice surgery 
in most patients with Pituitary Adenoma except 
for the Prolactinomas responsive to dopamine 
agonists. Treatments such as radiotherapy or 
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stereotactic radiosurgery may be offered to those 
patients who don’t benefit from surgery.2 
 Transsphenoidal surgery for pituitary 
adenomas has a very low incidence of 
complications and even lower mortality. Transient 
diabetes insipidus due to CSF leak and post-op 
hematoma is a complication that is apprehended. 
The mortality rate has also been reported very 
low and the complication rate is acceptable. The 
prevalence of complications after endoscopic TSS 
has been reported between 3 – 36%, which are 
mostly due to the CSF leak, dysfunction of the 
anterior lobe, and diabetes insipidus (DI).3-4 
Rehman et al (2018)4 reported around 31% 
complications from TSS. 
 Endoscopic transsphenoidal surgery (ETSS) for 
pituitary adenomas is superior to microscopic 
approach in the treatment of large sized pituitary 
adenomas. The postoperative complications are 
comparable. However, in increased tumor size, 
the success rate can be lower in both approaches 
owing to lateral extension and invasion of the 
cavernous sinus.2,5 Pituitary adenomas were most 
effectively addressed and the treatment was most 
rewarding when it is detected early followed by 
rendering prompt and relevant treatment. In 
another study, it has been concluded that 
endoscopic transsphenoidal surgery is an 
effective and safe modality for pituitary 
adenoma’s treatment and can be employed as a 
first-choice therapy.6-7 The objective of the 
current study was to report the efficacy, safety, 
clinical outcomes and complications of 
endoscopic endonasal transsphenoidal 
techniques for pituitary adenomas. 
 
MATERIAL AND METHODS 
Study Design & Setting 
A retrospective observational study of 3 years 
from was carried out in the Department of 
Neurosurgery Prime Teaching Hospital Peshawar, 
Pakistan. Total of 89 patients was included. 
Inclusion Criteria 
Patients of both genders of ages between 15 to 
70 years were included. Patients with Sellar 
Suprasellar tumor were included who were 
amenable to endoscopic approach. 
 
Exclusion Criteria 
Cases of the recurrent tumors were excluded. 
Those patients were also excluded who were not 
fit for surgery. 
 
Endoscopic Endonasal Transsphenoidal 
Surgery (ETSS) – Pituitary Adenomas 
The patient was placed in the supine position with 
head raised at 30 degrees. The approach was 
through the ipsilateral nostril, traversing the 
middle turbinate and to the sphenoid sinus. The 
ETSS approach was incorporated with endoscopic 
visualization. Paraseptal approach (between mid-
turbinate and nasal septum) was utilized via. 
patient’s nasal air-passage.8 
 The whole procedure benefitted from 
endoscopic visualization. Use of the endoscope 
through the middle turbinates required a small 
incision in the back of the nasal septum. We used 
surgical chisels and drills to cut through the bony 
wall and sinus.8 The sphenoid sinus was opened 
to reach the gland and excision of the tumor 
carried out. There were advantages of going 
through the transsphenoidal approach. The brain 
was not touched and so the chances of brain 
injury were extremely low. This approach leaves 
no scar. However, transsphenoidal surgery takes a 
longer time and it’s hard to take out large tumors 
through this approach.7,9 Figure 1 showing an 
axial view MRI brain T2 weighted image showing 
large pituitary adenoma. Figure 2 shows a 




Pituitary adenoma was diagnosed on MRI Brain
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with contrast and post-surgical biopsy. 
Background and clinical information were 
collected through a designed proforma. Surgical 




Figure 1:  Axial view MRI brain T2 weighted image showing 




Figure 2:  Sagittal MRI with contrast showing Sellar 
Suprasellar mass. 
documented. The data was analyzed through 
statistical IBM software SPSS version 23. 
 
RESULTS 
Background Information & Clinical 
Presentation 
Out of 89 patients, 48 (54%) were male and 41 
(46%) female patients. The mean age was 42 ± 5 
years. Headache was reported in 82 (92%) 
patients as a most common presentation. A 
decreased visual acuity was reported in 56 (62%), 
amenorrhea in 19 (22%), and acromegaly in 26 
(29%) patients (Table 1). 
 
Surgical Outcome 
Surgical outcome was found good (i.e., 80%) in 
patients with microadenomas as compared to 
patients with macroadenomas (61%). Whereas, 
tumors invading the cavernous sinus had a poor 
outcome, where only 22% improvement was 
observed (Table 1). Overall, the early surgical 




The most common complication was the transient 
diabetes insipidus followed by CSF leak and post-
op hematoma. The mortality reported in 5 (5.6%) 
patients. 
 
Table 1:  Clinical Presentation and Surgical Outcomes 
n = 89. 
Clinical Presentation 
Headache 92% 
Decreased Visual Acuity 62% 
Amenorrhea 22% 
Acromegaly 29% 
Status of Surgical Outcome 
Microadenomas 80% (Good) 
Macroadenomas 61% (Satisfactory) 
Tumors Invading the Cavernous Sinus 22% (Poor) 
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DISCUSSION 
Pituitary tumors are quite challenging sellar 
region lesions. Surgery has improved 
tremendously over the last millennium. The most 
revolutionary development has been the use of 
endoscopy.10 The current study reported the 
retrospective clinical outcome and complications 
of endoscopic endonasal transsphenoidal surgery 
(ETSS) for pituitary adenomas in our clinical 
setting of Neurosurgery Prime Teaching Hospital. 
An early surgical improvement related to the 
reported symptoms was achieved in 72% of 
patients. The majority of patients reported a good 
surgical outcome in patients with 
microadenomas. The most common complication 
was the transient diabetes insipidus followed by 
CSF leak and post-op hematoma. We found that 
the headache was the most common clinical 
presentation. The mortality reported in only 5.6% 
of patient. 
 Pinar et al (2015)7 included 32 patients in the 
age range between 23 – 74 years. In their study, 
68.8% of patients had functioning adenomas and 
31% of patients had nonfunctioning tumors. 
62.5% had macroadenomas and 37.5% had 
microadenomas. The cavernous sinus extension 
and suprasellar extension were radiologically seen 
in 60% of those having macroadenomas. CSF 
leakage occurred in only three patients and two 
patients developed diabetes insipidus. In a study 
by Gondim et al (2015),10 endoscopic surgery was 
performed in 55 patients age 70 between 70 and 
84 years. These patients were followed up for an 
average of 50 months. 69% of patients had visual 
impairment, 29% had headaches, and 11% had 
complete ophthalmoplegia. A 3 score of the 
American Society of Anesthesiologists was seen in 
the elderly patients and, it did not have any effect 
on the surgical extent of resection (EOR) or 
duration of stay in hospital. Complications were 
more common in elderly patients with age more 
than 60 years. They reported that 9% of patients 
had CSF leaks, 3.6% of patients had diabetes 
insipidus, 7.2% had refractory hypertension, 1.8% 
had a myocardial infarction and one had died. 
The new anterior pituitary deficit was seen post-
operatively in younger patients more commonly 
as compared to the elderly, as statistically 
insignificant. 
 A recent study conducted by Pereira et al 
(2020) 11 also evaluated demographics, outcomes, 
and complications after surgery of 
nonfunctioning tumors in elderly versus non-
elderly patients. In their study, 294 patients were 
elderly and 614 were non-elderly. Patients' sex, 
tumor size, and invasion of cavernous sinus were 
found similar in the two groups. Post-surgical 
outcomes like duration of admission, EOR, 
leakage of CSF requiring repair, re-admission 
within 30 days, rate of infection, and development 
of new hypopituitarism were also very similar. 
Adjuvant radiation was not readily given to 
elderly patients neither were they re-operated as 
opposed to younger adults. They found that the 
post-operative Diabetes Insipidus (DI) occurred 
less commonly in the elderly group as compared 
to the non-elderly group. Postoperative 
hyponatremia was 26.7% as compared to 16.4% 
in younger patients. The development of new 
neurological deficits was also less common in the 
elderly group. A sub-analysis of the elderly group 
highlighted that those having higher scores in the 
Charlson comorbidity index had similar outcomes 
in the younger group, with the exception of 
higher DI rates. Peaks and troughs of 
postoperative serum sodium levels were seen on 
the third day and ninth day in the elderly group, 
while in the non-elderly group these were noticed 
on the second day 2 and 8th of surgery. Pereira 
et al (2020)11 reported that for nonfunctioning 
pituitary adenomas, the procedure of TSS is safe 
and has a low incidence of complications. 
 Jang et al (2016)12 reported that 15.4% of 
patients developed complications post-
operatively. Diabetes insipidus was found to occur 
temporarily in 14 cases and only 3 patients 
developed it permanently. Nine patients had 
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syndrome of inappropriate antidiuretic hormone 
(SIADH), 6 cases had CSF leaks. Only one patient 
died due to the procedure. Progression occurred 
in 27.8% of patients which took an average period 
of 23.7 months. The mean follow-up period was 
68.5 months. The average duration of 
hospitalization was 4.4 (±1.6) days. Gondim et al 
(2010)13 conducted a study to determine the 
efficacy and safety of endoscopic excision for 
pituitary tumors. They included 288 consecutive 
patients who had endonasal endoscopic surgeries 
for the removal of adenomas. They did not report 
any mortality from the procedure ETSS. They 
concluded that the ETSS approach is an 
acceptable and best alternative to the 
microscopic procedure, as it is less invasive and 
includes fewer complications. This procedure also 
gives an excellent tumor removal rate. 
 
CONCLUSION 
The overall rate of early surgical improvement in 
symptoms was observed in 72% of patients. The 
majority of the patients reported a good surgical 
outcome in patients with microadenomas. We 
conclude that endoscopic endonasal 
transsphenoidal surgery is a safe, less invasive, 
cosmetically effective technological advancement 
for pituitary adenomas. 
 
RECOMMENDATIONS 
There are certain significant advantages of 
endoscopic surgery, however, it does not totally 
oust microsurgery, which has certain advantages 
too. More studies are required as prospective 
randomized trials to evaluate the profoundness of 
endoscopy in the resection of pituitary adenomas. 
Although, the tool of ETSS provides satisfactory 
results, however, it mainly deals with the 
reduction of large adenomas.10,13 The study 
results can help in discussions regarding 
operation and complications of endoscopic 
endonasal transsphenoidal surgery patients with 
pituitary adenoma. 
REFERENCES 
1. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, 
Vance ML, et al. The prevalence of pituitary 
adenomas: a systematic review. Cancer: 
Interdisciplinary International Journal of the 
American Cancer Society, 2004; 101 (3): 613-9. 
2. Akbari H, Malek M, Ghorbani M, Ramak Hashemi 
SM, Khamseh ME, Zare Mehrjardi A, et al. Clinical 
outcomes of endoscopic versus microscopic trans-
sphenoidal surgery for large pituitary adenoma. 
British Journal of Neurosurgery, 2018; 32 (2): 206-
9. 
3. Cavallo LM, Solari D, Tasiou A, Esposito F, de 
Angelis M, D'Enza AI, et al. Endoscopic endonasal 
transsphenoidal removal of recurrent and 
regrowing pituitary adenomas: experience on a 59-
patient series. World Neurosurgery, 2013; 80 (3-4): 
342-50. 
4. Rehman L, Rehman UL, Jabeen R, Rizvi R. 
Endoscopic Trans-Sphenoidal surgery; Efficacy and 
response in Pituitary Adenoma. Pakistan Journal of 
Medical Sciences, 2018; 34 (2): 412. 
5. Guvenc G, Kizmazoglu C, Pinar E, Imre A, Kaya I, 
Bezircioglu H, et al. Outcomes and complications 
of endoscopic versus microscopic transsphenoidal 
surgery in pituitary adenoma. Journal of 
Craniofacial Surgery, 2016; 27 (4): 1015-20. 
6. Wang F, Zhou T, Wei S, Meng X, Zhang J, Hou Y, 
et al. Endoscopic endonasal transsphenoidal 
surgery of 1,166 pituitary adenomas. Surgical 
Endoscopy, 2015; 29 (6): 1270-80. 
7. Pinar E, Yuceer N, Imre A, Guvenc G, Gundogan O. 
Endoscopic endonasal transsphenoidal surgery for 
pituitary adenomas. Journal of Craniofacial 
Surgery, 2015; 26 (1): 201-5. 
8. Tataranu L, Gorgan M, Ciubotaru V, Dediu A, Ene B, 
Paunescu D, et al. Endoscopic Endonasal 
Transsphenoidal Approach in the Management of 
Sellar and Parasellar Lesions: and Standard Surgical 
Technique (Part I). Romanian Neurosurgery, 2010: 
52-63. 
9. Cappabianca P, Cavallo LM, De Divitiis E. 
Endoscopic endonasal transsphenoidal surgery. 
Neurosurgery, 2004; 55 (4): 933-41. 
10. Gondim JA, Almeida JP, de Albuquerque LAF, 
Gomes E, Schops M, Mota JI. Endoscopic 
endonasal transsphenoidal surgery in elderly 
Musawer Khan, et al: Clinical Outcome and Complication of Endoscopic Endonasal Transsphenoidal Surgery (ETSS) for Pituitary 
 
http//www.pakjns.org         Pak. J. of Neurol. Surg. –2021 – 25 (1): 57-62.        62   
 
patients with pituitary adenomas. Journal of 
Neurosurgery, 2015; 123 (1): 31-8. 
11. Pereira MP, Oh T, Joshi RS, Haddad AF, Pereira KM, 
Osorio RC, et al. Clinical characteristics and 
outcomes in elderly patients undergoing 
transsphenoidal surgery for nonfunctioning 
pituitary adenoma. Neurosurgical Focus, 2020; 49 
(4): E19. 
12. Jang JH, Kim KH, Lee YM, Kim JS, Kim YZ. Surgical
results of pure endoscopic endonasal 
transsphenoidal surgery for 331 pituitary 
adenomas: a 15-year experience from a single 
institution. World Neurosurgery, 2016; 96: 545-55. 
13. Gondim JA, Schops M, de Almeida JPC, de 
Albuquerque LAF, Gomes E, Ferraz T, et al. 
Endoscopic endonasal transsphenoidal surgery: 
surgical results of 228 pituitary adenomas treated 





Disclosures:  Authors report no conflict of interest. 
Ethical Review Board Approval:  The study was retrospective. No approval required.  
However, institutional ethical rules were followed.  
Conflicts of Interest: 
In compliance with the ICMJE uniform disclosure form, all authors declare the following: 
Financial Relationships:  All authors have declared that they have no financial relationships at present or within 
the previous three years with any organizations that might have an interest in the submitted work. 
Other Relationships:  All authors have declared that there are no other relationships or activities that could 






Sr.# Author’s Full Name Intellectual Contribution to Paper in Terms of: 
1. Musawer Khan Analysis of data, study design and methodology. 
2. Arif Hussain Literature, manuscript writing and data collection. 
3. Mumtaz Ali Interpretation of results and quality assurer. 
 
 
 
